ArticleCase reports in nephrology2026
Minimal Change Disease With Mesangial IgA Deposition: A Clinicopathological Case Series From a Tunisian Referral Center.
Article in Case reports in nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Minimal change disease (MCD) associated with mesangial immunoglobulin A (IgA) deposition, historically referred to as "IgA Nephrosis," is a rare and nosologically controversial entity. Whether it represents MCD with incidental mesangial IgA deposition, a dual glomerulopathy combining MCD and subclinical IgA nephropathy (IgAN), or a distinct clinicopathological phenotype remains uncertain. Only isolated case reports and small series have been published to date. Methods: We retrospectively identified six consecutive patients (three children/adolescents and three adults; four males and two females) evaluated at the Kidney Pathology Laboratory of the Department of Nephrology, Charles Nicolle Hospital, Tunis, between 1995 and 2025. All patients presented with nephrotic syndrome, minimal or absent glomerular abnormalities on light microscopy, and dominant mesangial IgA deposits on direct immunofluorescence. Results: Microscopic hematuria was present in three patients, while one patient reported a remote episode of macroscopic hematuria during childhood. Light microscopy revealed essentially normal glomeruli in three cases and only mild mesangial hypercellularity and/or matrix expansion in the remaining cases, without endocapillary proliferation, crescents, necrotizing lesions, or significant chronic damage. Immunofluorescence consistently demonstrated dominant or exclusive mesangial IgA deposits, variably associated with IgM, IgG, C3, C1q, fibrinogen, or light-chain co-deposition. Electron microscopy was unavailable. Most patients exhibited steroid-sensitive disease, although relapsing courses were frequent. Conclusions: MCD with mesangial IgA deposition represents an uncommon clinicopathological entity situated at the interface between MCD and IgAN. The marked discrepancy between severe nephrotic syndrome and minimal histological lesions despite mesangial IgA deposition strongly suggests a predominant podocytopathy rather than classical proliferative IgAN. Recognition of this phenotype is important to avoid diagnostic misclassification and inappropriate therapeutic strategies. Further studies integrating ultrastructural and molecular analyses are required to clarify its pathogenesis and nosological position.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.